UBS AM’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.48M | Sell |
|
|||||
|
2025
Q2 | $7.2M | Buy |
|
|||||
|
2025
Q1 | $8.75M | Buy |
|
|||||
|
2024
Q4 | $9.03M | Buy |
|
|||||
|
2024
Q3 | $5.2M | Sell |
|
|||||
|
2024
Q2 | $5.3M | Buy |
|
|||||
|
2024
Q1 | $2.96M | Sell |
|
|||||
|
2023
Q4 | $3.66M | Buy |
|
|||||
|
2023
Q3 | $2.99M | Sell |
|
|||||
|
2023
Q2 | $3.01M | Hold |
|
|||||
|
2023
Q1 | $3.01M | Buy |
|
|||||
|
2022
Q4 | $3.05M | Buy |
|
|||||
|
2022
Q3 | $2.31M | Sell |
|
|||||
|
2022
Q2 | $2.92M | Buy |
|
|||||
|
2022
Q1 | $2.55M | Sell |
|
|||||
|
2021
Q4 | $3.23M | Sell |
|
|||||
|
2021
Q3 | $2.73M | Sell |
|
|||||
|
2021
Q2 | $3.13M | Buy |
|
|||||
|
2021
Q1 | $3.11M | Buy |
|
|||||
|
2020
Q4 | $6.65M | Sell |
|
|||||
|
2020
Q3 | $21.3M | Buy |
|
|||||
|
2020
Q2 | $4.38M | Sell |
|
|||||
|
2020
Q1 | $2.72M | Buy |
|
|||||
|
2019
Q4 | $2.69M | Buy |
|
|||||
|
2019
Q3 | $1.99M | Buy |
|
|||||
|
2019
Q2 | $2.6M | Buy |
|
|||||
|
2019
Q1 | $2.15M | Buy |
|
|||||
|
2018
Q4 | $1.32M | Buy |
|
|||||
|
2018
Q3 | $1.42M | Sell |
|
|||||
|
2018
Q2 | $1.86M | Sell |
|
|||||
|
2018
Q1 | $1.86M | Buy |
|
|||||
|
2017
Q4 | $1.51M | Buy |
|
|||||
|
2017
Q3 | $967K | Buy |
|
|||||
|
2017
Q2 | $511K | Buy |
|
|||||
|
2017
Q1 | $361K | Buy |
|
|||||
|
2016
Q4 | $147K | Sell |
|
|||||
|
2016
Q3 | $333K | Hold |
|
|||||
|
2016
Q2 | $246K | Sell |
|
|||||
|
2016
Q1 | $5.03M | Sell |
|
|||||
|
2015
Q4 | $9.28M | Buy |
|
|||||
|
2015
Q3 | $13.3M | Sell |
|
|||||
|
2015
Q2 | $14.6M | Buy |
|
|||||
|
2015
Q1 | $11M | Buy |
|
|||||
|
2014
Q4 | $8.26M | Buy |
|
|||||
|
2014
Q3 | $5.87M | Sell |
|
|||||
|
2014
Q2 | $4.58M | Sell |
|
|||||
|
2014
Q1 | $5.08M | Hold |
|
|||||
|
2013
Q4 | $5.77M | Hold |
|
|||||
|
2013
Q3 | $5.7M | Buy |
|
|||||
|
2013
Q2 | $2.9M | Buy |
|